Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > ASH December 5 to 8
View:
Post by Lesalpes29 on Nov 26, 2020 8:36am

ASH December 5 to 8

Pelareorep and Opdivo Phase 1 intrim data due at ASH. Found that on biopharmcatalyst. Do we know for sure if they are going to present data?
Comment by YegJeeber on Nov 26, 2020 1:12pm
I spoke with Kirk Look yesterday, and he confirmed ONCY is not participating in ASH, nor are any collaborators in Pelareorep based trials. Have no idea what BioPharmaCatalyst is doing noting that .....
Comment by canadafan on Nov 26, 2020 7:46pm
Perhaps a miss-name of the event? as ONC is clearly reporting as noted bellow: :Not only are they presenting one-but 3 separate trial results. That being the week of Dec 5-8th.perhaps being on the 9th confused people as not within the 5-8th week..lol //stockhouse.com/news/press-releases/2020/11/17/oncolytics-biotech-xae-to-present-aware-1-data-and-provide-updates-on-phase-2 Sanantonio Brest ...more  
Comment by JohnnyYeg on Nov 26, 2020 9:08pm
Actually I saw the screenshot of the Biopharmacatalyst.com. webpage that "promoted" ONC at the ASH event. It was obviously something they were trying to again promote. Makes me question their integrity.
Oncolytics Biotech Inc